← Scroll for more →
Generate Biomedicines, Inc. (GENB)
Pharmaceutical Preparations
Latest Price
$14.46
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.56
P/B Ratio
4.06
Institutional Ownership
77.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Flagship Pioneering, LLC | 62.67M | $1.06B | 48.86% | -- | 2026-06-30 |
| FMR LLC | 5.22M | $88.0M | 4.07% | +1.00M | 2026-06-30 |
| Capital World Investors | 4.22M | $71.0M | 3.29% | +211.5K | 2026-06-30 |
| Braidwell LP | 3.28M | $55.0M | 2.56% | -309.2K | 2026-06-30 |
| Price T Rowe Associates Inc | 2.16M | $36.0M | 1.68% | +47.0K | 2026-06-30 |
| Norges Bank | 2.09M | $35.0M | 1.63% | -- | 2026-06-30 |
| ARCH Venture Management, LLC | 1.94M | $32.0M | 1.52% | -- | 2026-06-30 |
| HarbourVest Partners LLC | 1.72M | $29.0M | 1.34% | -- | 2026-06-30 |
| BlackRock, Inc. | 1.66M | $28.0M | 1.29% | -- | 2026-06-30 |
| Baker Bros. Advisors LP | 1.42M | $24.0M | 1.11% | -- | 2026-06-30 |